Ab Initio Study of Prednisolone, 6α-Fluoroprednisolone, 9α-Fluoroprednisolone,and 6α,9α-Difluoroprednisolone

A theoretical study of prednisolone, 6-fluoroprednisolone, 9-fluoroprednisolone, and 6,9-difluoroprednisolone has been performed at the ab initio HF/6-31G, MP2/6-31G, and B3LYP/6-31G levels. Structural information and the electronic features of prednisolone and its derivatives and the synergistic effect of 6,9-difluoroprednisolone was examined. Contrary to the AM1 and MNDO results, we found 9-fluoroprednisolone is more stable than the 6-fluoroprednisolone. The increased corticosteroid activity of the 6,9-difluoroprednisolone is most likely due to electronic effects, mainly related to the receptor binding.     

6α-羟基紫杉醇的合成

以紫杉醇为原料,经过羟基保护、磺酸化、烯化、双羟基化、构型翻转、去除保护基,得到6α-羟基紫杉醇。目标化合物和中间体的结构经1H NMR、MS确证,总收率为3.97%。     

A MULTIGRAM PREPARATIVE SYNTHESIS OF CHOLEST-4-EN-3α,6β- AND -3α,6α-DIOLS

A preparative synthesis of cholest-4-en-3α,6β- and -3α,6α-diols 10 and 15 using cheap reagents and simple working-up procedures without chromatography on a multigram scale is described.     

6α-甲基-17α-乙酰氧基黄体酮的合成

甾体激素往往因分子中在 C_6的α-位置加入一甲基而增强其疗效,例如6α-甲基可的松及6α-甲基可的唑(Ⅰ)均比其母体的功效大得多,黄体酮在 C_(17)上加入一乙酰氧基可使其疗效较为持久,若再在 C_6-α位置上加入甲基则不但疗效比母体大五、六十倍,并可内服,而黄体酮则只能注射,此物(Ⅺ)的已知合成方法中,似以 Babcock 等的方法较为简便。其法是用17α-羟基黄体酮(Ⅱ)为原料,即先作成 A 环上应有的不饱和酮簇,然后再加入6α-甲基,最后引入17α-乙酰氧基得Ⅺ。     

6α和6β-羟基去氧胆酸的合成

6α和6β-羟基去氧胆酸[DCA-6α-ol (6)和DCA-6β-ol (7)]是新近鉴定的两个来自于人类肝脏的重要三级胆汁酸代谢产物.以胆酸(1)为起始原料经10步反应方便快捷地同时实现DCA-6α-ol(6)和DCA-6β-ol(7)的合成.路线涉及Mukaiyama羟醛缩合、臭氧裂解和SmI_2促进的羰基邻位还原脱氧等关键反应.     

Synthesis of 5α-Iodo-6-one Steroids

Abstract: The synthesis of 5-iodo-5α-cholestan-6-one (6), its 3β-acetoxy-(7) and 3β-chloro-(8) analogues, 3β-acetoxy-5-iodo-5α-stigmastan-6-one (9) and its 3β-chloro-(10) analogue by the reacion of silver chromate-iodine and pyridine with the corresponding steroidal olefins (1-5) is described. The structures of these products have been established on the basis of their elemental, analytical and spectral data.     

Synthesis of 3β,6α-dihydroxy-5α-cholan-23-one

Evidence for the presence of 3β,6α-dihydroxy-5α-chol-9(11)-en-23-one in the aglycone mixture from the starfish Marthasterias glacialis is provided by the synthesis of 3β,6α-dihydroxy-5α-cholan-23-one (19) and its identification in the hydrogenated aglycone mixture. The side-chain is constructed from the 23,24-dinorcholanol (13) by reaction of the 22-tosylate (16) with the acetylide anion, followed by hydration of the resulting 23-yne (17).     

Reaction of 3β-chloro-5α,6α-epoxysteroids with trifluoroacetic acid

It has been established that on the interaction of the 5,6-epoxysteroids (1a–c) with trifluoroacetic acid in chloroform the 6-trifluoroacetates of the 5,6-diols (2a–c) are formed in high yield. The alkaline hydrolysis of the trifluoroacetates (2a–c) leads to the corresponding diols (3a–c).Institute of Bioorganic Chemistry, Belarus' National Academy of Sciences, 220141, Belarus', Minsk, ul. Akad. Kuprevicha, 5/2. Translated from Khimiya prirodnykh Soedinenii, No. 2, pp. 201–204, March–April, 1999.     

Derivatives Of α-Cyclodextrin and the Synthesis of 6-O-α-D-Glucopyranosyl-α-Cyclodextrin

Abstract

Regioselective silylation of α-cyclodextrin with tert-butyl-dimethylsilyl chloride in N, N-dimethylformamide in the presence of imidazole gave, in 75% yield, the hexakis(6-O-tert-butyldimethylsilyl) derivative 2, which was transformed into the hexakis(2,3-di-O-methyl, 6-O-methyl, 2,3-di-O-propyl, and 2,3-di-O-acetyl) derivatives. On methanesulfonylation and p-toluenesulfonylation, the hexakis(2,3-di-O-acetyl) derivative 16 afforded the hexakis(2,3-di-O-acetyl-6-O-methylsulfonyl 17 and 2,3-di-O-acetyl-6-O-p -tolylsulfonyl 18) derivatives, respectively. Nucleophilic displacement of 17 and 18 with iodide, bromide, chloride, and azide ions afforded the hexakis(6-deoxy-6-iodo 19, 6-bromo-6-deoxy, 6-chloro-6-deoxy, and 6-azido-6-deoxy) derivatives, respectively, of α-cyclodextrin dodeca-acetate. The hexakis (2, 3-di-O-acetyl-6-deoxy) derivative was prepared from 19. Selective glucosylation of 16 with 2,3,4,6-tetra-O-benzyl-α-D-glucopyranosyl bromide under catalysis by halide ion, followed by removal of protecting groups, furnished 6-O-α-D-glucopyranosyl-α-cyclodextrin.     

6α-甲基副肾皮醇乙酸酯的合成

分析:C_(24)H_(34)O_6计算值%:C,68.87;H,8.19实验值%:C,68.87;H,7.82用合成副肾皮酮(Cortisone)的中间体(Ⅰ)为原料经七步合成6α-甲基副肾皮醇乙酸酯。     

A FACILE TOTAL SYNTHESIS OF 6-PENTYL-α-PYRONE

ＡＦＡＣＩＬＥＴＯＴＡＬＳＹＮＴＨＥＳＩＳＯＦ６－ＰＥＮＴＹＬ－α－ＰＹＲＯＮＥ￥ＣｈｉＺＨＡＮＧ；ＸｕｅＣｈａｏＷＡＮＧ；ＦａｎｇＮｉｎｇＺＨＡＮＧａｎｄＸｉｎＦｕＰＡＮ（ＤｅｐａｒｔｍｅｎｔｏｆＣｈｅｍｉｓｔｒｙ，ＳｔａｔｅＫｅｙＬａｂｏｒａｔｏ...     

Syntheses of P-Nitrophenyl 6-O-α- and 6-O-β-D-Xylopyranosyl-β-D-glucopyranoside

Condensation of p-nitrophenyl 2,3,4-tri-O-benzoyl-β-D-glucopyranoside 3 with 2,3,4-tri-O-(chlorosulfonyl)-β-D-xylopyranosyl chloride by the Koenigs-Knorr method afforded the α-linked product in a high yield. Dechlorosulfation with sodium iodide and debenzoylation by the Zemplen method gave crystalline p-nitrophenyl 6-O-(α-D-xylopyranosyl)-β-D-glucopyranoside 7.

Compound 3 was condensed with 2,3,4-tri-O-benzoyl-α-D-xylopyranosyl bromide in the presence of mercury (II) cyanide in acetonitrile, and after debenzoylation, crystalline p-nitrophenyl 6-O-(β-D-xylopyranosyl)-β-D-glucopyranoside 10 was obtained.     

Convenient Preparation of 2,3,4, 6-Tetra-O-methyl-α-D-glocopyranosyl Bromide

2,3,4,6-Tetrar-O-methyl-α-D-glucopyranosyl bromide (3) is conveniently prepared by treatment of 2,3,4,6-tetra-O-methyl-D-glucose with HBr. This procedure is easier and produces higher yields than previously reported syntheses.     

Studies on stereocontrolled epoxidations of bis-alicyclic alcohols in steroidal skeletons: preparation of eight diastereomerically pure epoxides from cholest-4-en-3β,6β-; -3β,6α-; -3α,6β- and -3α,6α-diols

Eight diastereomerically pure epoxides have been prepared from cholest-4-en-3β,6β; -3β,6α-; -3α,6β- and -3α,6α-diols via a combination of steric, protecting group and oxidant effects on stereocontrolled epoxidations of a bis-alicyclic alcohol system within the steroidal skeleton.     

6-甲基甾体激素——△~6-6-甲基-17α-羟基黄体酮

副腎皮激素如可的松(Cortisone)及可的唑(Cortisol)等在 C_6-α位置引入一甲基,则疗效可以大为加强。又此类激素,如在 C_(6.7)加入双键,则往往效力亦可加大。因此我们设计合成本题所述的化合物,因其分子中在 C_6处既有甲基,又有双键,所以期待它们具更大的生理作用。     

6α和6β-羟基雄酮的电子光谱和核磁共振谱的理论研究

在B3LYP/6-31G(d)水平下,优化6α和6β-羟基雄酮的几何构型.用TD-B3LYP/6-31G(d)方法,计算它们的电子吸收光谱;采用规范不变原子轨道GIAO法,计算它们的1H-NMR和13C-NMR化学位移值.结果表明,6β-羟基雄酮比6α-羟基雄酮稳定;6α-羟基雄酮的最长吸收波长比6β-羟基雄酮的要长;6α和6β-羟基雄酮的部分原子的NMR值具有明显差别.     

New case of closure of a 5α, 6α-oxide ring in the androstane series

Russian Chemical Bulletin -     

Reaction of 5β,6β-epoxy-16α,17α-cyclohexapregnane with methylmagnesium iodide

On treatment with methylmagnesium iodide, 3β-acetoxy-5β,6β-epoxy-16α,17α-cyclo-hexapregnan-20-one undergoes 3-O-deacetylation along with the opening of the 5β,6β-epoxide ring to form 5α-methyl-6β-hydroxy steroid and the 6α-methyl-6β-hydroxy isomer, the 20-keto group remaining intact.     

6α-甲基-强的松龙乙酸酯合成的改进方法

6α-甲基强的松龙乙酸酯(6α-Methyl-pre-dnisolone acetate)4是不含氟的甾体皮质激素药物,在国外已广泛用于临床。我们曾报道将6α-甲基-11β,17α-二羟基-黄体酮1以I_2、CaO处理,转变成碘化物后,不需分离就可将碘化物与KOAc进行置换,得6α-甲基-可的唑乙酸酯2。2用DDQ进行脱氢,得产物4的收率仪55%。因而我们改用化合物1作底物,先经节杆菌(Arthrobacter simplex)脱氢可